• HOME
  • COMPANY
  • Leadership
iPSC Therapeutics for the Best

SEOUL

Therabest Headquarters

  • Pyung-Suk Ki, M.D
    CEO & Founder

    Chonnam National University Medical School (Neuro Psychiatry)

    Gaeun Hospital, Founder

    Therabest, Founder

  • Do-Won Hwang, Ph.D
    CTO

    Seoul National University, Ph.D (Neuroscience)

    Seoul National University, BK Associate Professor

    Harvard MGH Hospital Visiting scholar

  • Shin-Il Kim, Ph.D
    CSO

    University of Wisconsin-Madison, Ph.D (Molecular biology)

    University of California-San Francisco, Postdoctoral fellow

    Center for iPS Cell Research and Application (CiRA), Kyoto University, Assistant professor

    aceRNA Technologies Co., Ltd, Director, Division of R & D

    Therabest JAPAN, Co-CEO (Current)

  • Mun-Sang Lee
    CMO

    Chung-Ang University B.S. (Chemistry)

    Celltrion QC Part

    Samsung Biologics, QA Part leader

    Kangstem Biotech, QA Team leader

    SK Biopharmaceuticals, QA Principal Scientist

  • Young-Bae Shin
    CFO

    Sogang University B.A. (Business administration)

    Daewoo Securities Equity Brokerage, Private Banking, Strategy & Planning, Investor Relations

    Mirae Asset Daewoo, Investor Relations

    Mirae Asset Daewoo, Investment Banking (ECM)

SAN DIEGO

Therabest USA

  • Sung-Chang Lee, Ph.D
    CEO

    The University of Texas Medical Branch at Galveston, Ph.D (Cellular Physiology/MolecularBiophysics)

    Texas Tech University Health Sciences Center,Postdoc

    The Scripps Research Institute, Research Scientist

    California Institute for Biomedical Research (Calibr), Investigator